• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.68 0.04(5.07%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:0.72
    Open:0.63
    Bid:N/A
    Ask:5.99 x 100
    1y Target Est:9.00
    Beta:0.31
    Next Earnings Date:N/A
    Day's Range:0.63 - 0.70
    52wk Range:0.61 - 4.84
    Volume:493,658
    Avg Vol (3m):213,766
    Market Cap:15.70M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCDown 5.07%15.70M
    AZN90.54B
    JNJ295.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback